Come up with a name for your new list and we'll add to it:
Taiga Biotechnologies raised a round of funding on October 26, 2010. Investors include
National Institutes of Health.
Taiga Biotechnologies is a privately held developer of novel therapies for complex diseases including cancers, infectious agents such as HIV and influenza, and hematologic conditions. Each of the comp…